Why the study?
High-intensity statin use after MI varies by patient characteristics, but little is known about differences in use by hospital or region.
Are region, hospital, and patient characteristics associated with high-intensity statin use after myocardial infarction in Medicare beneficiaries?
Are region, hospital, and patient characteristics associated with high-intensity statin use after myocardial infarction in Medicare beneficiaries?
Geographic region is the strongest correlate of high-intensity statin use after myocardial infarction among Medicare beneficiaries, highlighting significant treatment disparities.
No takes yet. Share an insight, caveat, or question.
Regional disparities drive post-MI high-intensity statin use more than patient or hospital factors; leaves open targeted quality interventions.
Bittner et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: